Edward Burn

Mar 14, 2024 | dovepress.com | Nicola L. Barclay |Theresa Burkard |Edward Burn |Antonella Delmestri

Back to Journals » Clinical Epidemiology » Volume 16 Authors Barclay NL , Burkard T, Burn E , Delmestri A, Miquel Dominguez A, Golozar A, Guarner-Argente C , Avilés-Jurado FX, Man WY, Roselló Serrano À , Rosen AW , Tan EH , Tietzova I, Prieto Alhambra D , Newby D Received 14 March 2024 Accepted for publication 22 May 2024 Published 11 June 2024 Volume 2024:16 Pages 417—429 DOI https://doi.org/10.2147/CLEP.S463160 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer...

Sep 13, 2023 | jamanetwork.com | Eng Hooi Tan |Edward Burn |Nicola L. Barclay |Antonella Delmestri

Key PointsQuestion  What is the incidence, prevalence, and survival rates for prostate cancer from 2000 to 2021 using primary care data from the UK? Findings  In this cohort study of 198 125 patients in 2 UK databases, the incidence of prostate cancer increased from 109 per 100 000 person-years in 2000 to 159 per 100 000 person-years in 2021. Prevalence increased from 0.4% in 2000 to 1.4% in 2021.